Minda Industries Q4 Review – New Capex Cycle Begins: Systematix

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity t…

Read More

Capacite Infraprojects Q4 Review – Healthy Operating Performance, Lean Balance Sheet: Prabhudas Lilladher

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity t…

Read More

Stock Markets Live: SGX Nifty Subdued Amid Asian Trade Ahead Of Fed; Jubilant Foodworks, LIC Housing In Focus

SGX Nifty Subdued Amid Asian Trade Ahead Of FedGood morning!
Asian stocks traded mixed Tuesday after their U.S. peers closed at a record and a bond rally stalled ahead of a key Federal Reserve meeting. Commodities retreated.
Japanese shares…

Read More

Dodla Dairy IPO: What You Need To Know

Dodla Dairy Ltd. will launch its three-day initial public offering on Wednesday as the curd to milk-based sweets maker aims to lower debt, and promoters and investors look to pare holdings.
The maiden offer comprises a fresh issue worth up …

Read More

What Jhunjhunwala, Damani And Other Veteran Investors Bought And Sold In March Quarter

Indian equities gained in the quarter ended March, just before the deadlier second wave of Covid-19 infections stalled economic recovery.
The Nifty 50 rose 5.07% in the January-March period, posting its best fourth quarter since 2007, accor…

Read More

Novavax’s COVID-19 Vaccine Is Right on Target, Says Analyst

One of the early frontrunners in the race to get a Covid-19 vaccine to market, Novavax (NVAX) has encountered delays in getting its offering out to the public. But at last the results are in from the U.S/Mexican Phase 3 trial for NVX-CoV237…

Read More

Time to Load up on Atossa Shares? This Analyst Thinks So

The stock market, like any other industry, is riddled with clichés. One of the most commonly used is the ubiquitous “buy the rumor, sell the news.” However, clichés are not clichés without reason (another cliché…) and the old maxim could …

Read More

Why Brooklyn ImmunoTherapeutics Crushed the Market Today

Shares of Brooklyn ImmunoTherapeutics (NYSEMKT: BTX), no stranger to sharp stock price movements lately, zoomed more than 6% higher on Monday. The catalyst was an acquisition announced that morning by the clincial-stage biotech company.
In …

Read More

The Industry Powering the Digital Revolution

In this episode of Industry Focus: Tech, we’re switching things up a bit as Motley Fool contributor Jason Hall and analyst John Rotonti, with host Dylan Lewis, give you a breakdown of semiconductors: how semiconductors are made, the major p…

Read More

Why Azul Stock Is Up Today

Brazil’s Azul (NYSE: AZUL) remains optimistic the airline’s domestic market is in the early stages of a post-pandemic recovery, and the stock is flying higher as a result. Shares of Azul traded up as much as 5% on Monday.
Azul and other air…

Read More
  • BrokerEUR/USD
    ETX Capital 0.6pips (variable) margin: 3.33%
    CMC Markets 0.7pips. (variable) margin: 3.33%
  • Back to top